2025
Racial and ethnic disparities in conversion to mastectomy following lumpectomy
Khubchandani J, KC M, Dey P, Proussaloglou E, Valero M, Berger E, Park T, Gross C, Butler P, Fayanju O, Winer E, Golshan M, Greenup R. Racial and ethnic disparities in conversion to mastectomy following lumpectomy. Breast Cancer Research And Treatment 2025, 211: 99-110. PMID: 39937397, DOI: 10.1007/s10549-025-07625-6.Peer-Reviewed Original ResearchConceptsConversion to mastectomyNeoadjuvant chemotherapyBreast conservationStage 0-III breast cancerWhite womenBreast cancerBlack womenBreast cancer careNational Cancer DatabaseMultivariate logistic regression modelEvaluate contemporary trendsLogistic regression modelsCancer careImprove disparitiesEthnic disparitiesDiagnosis yearInitial lumpectomySocio-demographicCancer DatabaseClinical factorsMastectomyLumpectomySurgeryResultsThe studyTreatment sequence
2024
Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States
Reddy K, Jarrell K, Berkowitz C, Hulse S, Elmore L, Fishman R, Greenup R, Mateo A, Rothman J, Sataloff D, Tchou J, Zafar S, Fayanju O. Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States. Annals Of Surgical Oncology 2024, 32: 2534-2544. PMID: 39694997, PMCID: PMC11882630, DOI: 10.1245/s10434-024-16586-x.Peer-Reviewed Original ResearchConceptsBreast cancer careCancer careEmergency departmentBreast cancerWeighted proportion of patientsMedical Expenditure Panel SurveyPrescription medication expendituresOffice-based encountersProportion of patientsOffice-based visitsOut-of-pocketAssociated with increased resource utilizationChi-square testRao-ScottFinancial barriersHealthcare expendituresInpatient expendituresMedical careHealthcare spendingBreast cancer patientsMedical expendituresCareUnited StatesResource utilizationPanel Survey
2023
Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider Perspectives
Fayanju O, Greenup R, Zafar S, Hyslop T, Hwang E, Fish L. Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider Perspectives. Journal Of Surgical Research 2023, 284: 269-279. PMID: 36610386, PMCID: PMC10020986, DOI: 10.1016/j.jss.2022.11.074.Peer-Reviewed Original ResearchConceptsBreast cancer treatmentBreast cancerModifiable barriersCancer treatmentProvider perspectivesSurgical oncology careBreast cancer careAdvanced practice providersSingle health systemModifiable contributorOncologic careModifiable factorsOncology careCancer careTreatment receiptPatients' perceptionsStage 0Practice providersCare receiptPatientsExemplar quotesThematic analysisSuboptimal communicationHealth systemTreatment costs
2022
Genetic testing in privately insured women with surgically treated breast cancer
Dinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.Peer-Reviewed Original ResearchConceptsBreast cancerGenetic testingRoutine breast cancer careBRCA1/BRCA2 genetic testingHormone receptor statusBreast cancer careInvasive breast cancerBRCA2 genetic testingReceptor statusWomen 50Cancer careAge 45Family historyOlder womenInsurer databaseYoung womenCancerWomenCoverage policiesUnclear implicationsPatientsSurgeryPurposeRatesYearsPrevalenceTreatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021
Chehayeb R, Hood A, Wang X, Miksad R, Mougalian S, Lustberg M, Wang S, Greenup R, Pusztai L, Kunst N. Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021. JAMA Network Open 2022, 5: e2244204. PMID: 36445704, PMCID: PMC9709649, DOI: 10.1001/jamanetworkopen.2022.44204.Peer-Reviewed Original ResearchConceptsMetastatic breast cancerErbB2-positive metastatic breast cancerHR-positive metastatic breast cancerLines of therapyMBC subtypesDrug costsBreast cancerMedical costsHuman epidermal growth factor receptor 2 receptor statusMBC treatmentERBB2-negative metastatic breast cancerAssociated direct medical costsEarly-stage breast cancerHormone receptorsFlatiron Health databaseMetastatic recurrence ratesDifferent drug regimensBreast cancer careData of patientsDirect medical costsNovel adjuvant therapySupportive care drugsOutcomes of interestCost-effectiveness analysisAdjuvant therapyTreatment patterns and medical costs of metastatic breast cancer care in the United States.
Chehayeb R, Hood A, Mougalian S, Lustberg M, Wang S, Greenup R, Pusztai L, Kunst N. Treatment patterns and medical costs of metastatic breast cancer care in the United States. Journal Of Clinical Oncology 2022, 40: e18834-e18834. DOI: 10.1200/jco.2022.40.16_suppl.e18834.Peer-Reviewed Original ResearchMetastatic breast cancerTreatment patternsTreatment costsDiagnosis of MBCSocietal perspectiveHormone receptor statusBreast cancer careDays of diagnosisDe-identified databaseAverage wholesale priceElectronic health recordsMBC patientsMBC diagnosisReceptor statusCancer careInvasive cancerTriple NegativeClinical trialsReceptor subtypesPatient levelBreast cancerHuman epidermal growth factorPayer perspectiveDrug costsEpidermal growth factor
2020
Breast Surgery
Greenup R, Rosenberger L. Breast Surgery. Success In Academic Surgery 2020, 183-188. DOI: 10.1007/978-3-030-29271-3_20.Peer-Reviewed Original ResearchBreast surgeryQuality patient-centered careBreast surgical oncologyBreast cancer carePatient-centered careSuccessful clinical practiceRadiation oncology colleaguesBreast cancer researchHigh-quality patient-centred careCancer careSurgical oncologyReconstructive surgeryOncology colleaguesClinical practiceSurgeryBreast radiologistsCancer researchTrainee educationCareFocused effortsOncology
2018
The quality of breast cancer quality measures.
Lane W, Rushing C, Nussbaum D, Blazer D, Greenup R. The quality of breast cancer quality measures. Journal Of Clinical Oncology 2018, 36: 108-108. DOI: 10.1200/jco.2018.36.30_suppl.108.Peer-Reviewed Original ResearchBreast conserving surgeryContralateral prophylactic mastectomyImmediate breast reconstructionBreast cancer careBreast careCancer carePatient preferencesBreast cancer quality measuresMultivariable logistic regression modelFacility-level ratesHigh rateCancer quality measuresEarly-stage cancerLogistic regression modelsProbability of treatmentConserving surgeryEvidence-based practiceProphylactic mastectomyBreast reconstructionTreatment decisionsStage cancerAmerican CollegePatient valuesPredictive valuePatient choice
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply